These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19422865)

  • 1. Advancements in adenoviral based virotherapy for ovarian cancer.
    Matthews KS; Alvarez RD; Curiel DT
    Adv Drug Deliv Rev; 2009 Aug; 61(10):836-41. PubMed ID: 19422865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From gene therapy to virotherapy for ovarian cancer.
    Stoff-Khalili MA; Dall P; Curiel DT
    Minerva Ginecol; 2004 Dec; 56(6):503-14. PubMed ID: 15729203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral strategies for the gene therapy of cancer.
    Relph KL; Harrington KJ; Pandha H
    Semin Oncol; 2005 Dec; 32(6):573-82. PubMed ID: 16338423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of transcriptionally regulated oncolytic adenoviruses.
    Ko D; Hawkins L; Yu DC
    Oncogene; 2005 Nov; 24(52):7763-74. PubMed ID: 16299536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of a novel adenovirus formulation with artificial envelope of multilayer polymer-coatings: therapeutic effect on metastatic ovarian cancer.
    Yoshihara C; Hamada K; Koyama Y
    Oncol Rep; 2010 Mar; 23(3):733-8. PubMed ID: 20127013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic (replication-competent) adenoviruses as anticancer agents.
    Toth K; Dhar D; Wold WS
    Expert Opin Biol Ther; 2010 Mar; 10(3):353-68. PubMed ID: 20132057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral vectors--how to use them in cancer gene therapy?
    Majhen D; Ambriović-Ristov A
    Virus Res; 2006 Aug; 119(2):121-33. PubMed ID: 16533542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for malignant glioma: current clinical status.
    Pulkkanen KJ; Yla-Herttuala S
    Mol Ther; 2005 Oct; 12(4):585-98. PubMed ID: 16095972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer approaches for gynecological diseases.
    Raki M; Rein DT; Kanerva A; Hemminki A
    Mol Ther; 2006 Aug; 14(2):154-63. PubMed ID: 16650808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of retroviral and adenoviral approaches to cancer gene therapy.
    Yin LH; Fu SQ; Nanakorn T; Garcia-Sanchez F; Chung I; Cote R; Pizzorno G; Hanania E; Heimfeld S; Crystal R; Deisseroth A
    Stem Cells; 1998; 16 Suppl 1():247-50. PubMed ID: 11012168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 10-year follow-up of gene-modified adenoviral-based therapy in 146 non-small-cell lung cancer patients.
    Nemunaitis J; Vorhies JS; Pappen B; Senzer N
    Cancer Gene Ther; 2007 Aug; 14(8):762-3. PubMed ID: 17514194
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene therapy in the management of oral cancer: review of the literature.
    Ayllón Barbellido S; Campo Trapero J; Cano Sánchez J; Perea García MA; Escudero Castaño N; Bascones Martínez A
    Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E15-21. PubMed ID: 18167474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction: gene therapy of cancer.
    Lattime EC; Gerson S
    Semin Oncol; 2005 Dec; 32(6):535-6. PubMed ID: 16338418
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon beta adenoviral gene therapy in a patient with ovarian cancer.
    Sterman DH; Gillespie CT; Carroll RG; Coughlin CM; Lord EM; Sun J; Haas A; Recio A; Kaiser LR; Coukos G; June CH; Albelda SM; Vonderheide RH
    Nat Clin Pract Oncol; 2006 Nov; 3(11):633-9. PubMed ID: 17080181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer.
    Gonzalez-Pastor R; Goedegebuure PS; Curiel DT
    Cancer Gene Ther; 2021 May; 28(5):375-389. PubMed ID: 32951021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-peritoneal administration of genetic therapies: promises and pitfalls.
    Evans TR; Keith WN
    Minerva Ginecol; 2004 Dec; 56(6):529-38. PubMed ID: 15729205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted radiotherapy for prostate cancer with an oncolytic adenovirus coding for human sodium iodide symporter.
    Hakkarainen T; Rajecki M; Sarparanta M; Tenhunen M; Airaksinen AJ; Desmond RA; Kairemo K; Hemminki A
    Clin Cancer Res; 2009 Sep; 15(17):5396-403. PubMed ID: 19706820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of disseminated ovarian cancer using nonviral interleukin-12 gene therapy delivered intraperitoneally.
    Fewell JG; Matar MM; Rice JS; Brunhoeber E; Slobodkin G; Pence C; Worker M; Lewis DH; Anwer K
    J Gene Med; 2009 Aug; 11(8):718-28. PubMed ID: 19507172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients.
    Raki M; Sarkioja M; Escutenaire S; Kangasniemi L; Haavisto E; Kanerva A; Cerullo V; Joensuu T; Oksanen M; Pesonen S; Hemminki A
    J Gene Med; 2011 May; 13(5):253-61. PubMed ID: 21520358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy.
    Yang ZR; Wang HF; Zhao J; Peng YY; Wang J; Guinn BA; Huang LQ
    Cancer Gene Ther; 2007 Jul; 14(7):599-615. PubMed ID: 17479105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.